早期吸入不同浓度布地奈德对哮喘大鼠气道炎症和重构的干预被引量：1

Inhaled different Concentrations of Budesonide in Early Phase Interfere in Airway Inflammation and Remodeling in Asthmatic Rats

原文传递

导出

摘要目的:研究早期吸入不同浓度布地奈德对哮喘大鼠气道炎症和气道重构的干预情况。方法:32只Wistar大鼠随机分为4组:A对照组8只,B卵蛋白(OVA)致哮喘组8只,C卵蛋白致哮喘后吸入低浓度布地奈德治疗组8只,D卵蛋白致哮喘后吸入高浓度布地奈德治疗组8只。分别测定各组大鼠血中肿瘤坏死因子-α(TNF-α)及肺泡灌洗液(BALF)中内皮素-1(ET-1)的水平,计数BALF中细胞总数及分类。各组大鼠行肺组织切片HE染色,再行胶原染色、免疫组化NGF、TGF-β1染色,借助计算机图象分析软件测量单位气道面积炎性细胞数目,基底膜周径(Pbm)、平滑肌面积(WAm)、气道内壁面积(WAi)、胶原面积(Wcol),NGF及TGF-β1阳性信号积分吸光度。结果:B组BALF中细胞总数、嗜酸细胞分类及TNF-α、ET-1水平与A组比较均明显增加,差异有统计学意义(P<0.01),C组及D组较B组均明显降低,差异有统计学意义(P<0.01)。B组NGF及TGF-β1的表达、气道壁炎性细胞计数、气道内壁面积、平滑肌面积、胶原面积与A组比较均明显增加,差异有统计学意义(P<0.01),C组及D组与B组比较均明显降低,差异有统计学意义(P<0.01),C组及D组与A组比较差异有统计学意义(P<0.05,P<0.01),C组与D组差异均有统计学意义(P<0.05,P<0.01)。结论:早期吸入不同浓度的布地奈德均可明显抑制气道炎症和气道重构,高浓度较低浓度对气道炎症和气道重构的影响更明显。 Objective： To investigate the effect of inhaled different concentrations of budesonide in early phase on the airway inflammation and remodeling in asthmatic rats. Methods： Thirty-two rats were randomly divided into 4 groups： group A （n=8,control with saline）, groupB （n=8,asthrna with OVA）,group C （n=8, asthma with OVA treated with low concentrations ofbudesonide in early phase）, group D （n=8, asthma with OVA treated with high concentrations of budesonide in early phase）. The bronchoalveolar lavage fluids （BALF） were classification in BALF studied in each group, the pathologic alteration of the bronchi and lung tissue was observed by HE staining. Expression of NGF and TGF-[31 were detected by immunohistochemistry, collagen deposition by Masson staining. The Morphological parameters including the number of inflammatory cell per unit airway area, bronchial basement membrane perimeter（Pbm）, smooth muscle area（WAm）, inner airway area（WAi）, collagen area（Wcol） by computer image analysis software. Results： The total cell counts and the percentage of EOS in BALF the level of TNF-α , ET-1 increased compared with group A （P〈0.01）, group C and D reduced significantly compared with group B （P〈0.01）. The expression of NGF and TGF-β1, inflammatory cell counts around bronchus, airway smooth muscle hypertrophy ,the collagen deposition of reticular basement, airway inner wall area were significant higher than those groupA（P〈0.01 ）, the data in group C and D were significant lower than those in group B（P〈0.01 ）, there were apparent difference between group C and group D compared with group A （P〈0.05,P〈0.01）. The difference between group C and group D.（P〈0.05,P〈0.01 ） Conclusion： Inhaled different concentrations of budesonide in early phase could apparently inhibit airway inflammation and remodeling, high concentrations ofbudesonide than low concentrations.

作者梁蕊金寿德邵玉霞张新刘立杰荣海芳

机构地区哈尔滨医科大学附属第四医院哈尔滨医科大学附属第二医院

出处《现代生物医学进展》 CAS 2011年第21期4014-4018,共5页 Progress in Modern Biomedicine

关键词哮喘气道炎症重构布地奈德 Asthma Inflammation Remodeling Budesonide

分类号 Q95-3 [生物学—动物学] R562.25 [医药卫生—呼吸系统]

引文网络
相关文献

参考文献15

1Bateman ED, Hurd SS, BarnesPJ, et al. Global strategy for asthma management and prevention: GINA executive summary [J]. Respir J, 2008, 31(1): 143-178.
2Henderson WR, Tang LO,Chu S J, et al. A role for cysteinyl leukotrienes in a mouse asthma model [J]. Am J Respir Crit Care Med, 2002,165:108-116.
3Vignola AM, Mirabella F, Costanzo G, et al. Airway remodeling in asthma[J].Chest,2003,123(3): 417-422.
4Tang LK,Wilson JW,Stewart AG,et al.Airway remodelling in asthma: current understanding and implications for future therapies [J].Pharmacol Ther, 2006,112(2):474-488.
5Watson CS, Gametchu B, Proteins ofmultiple classesmay participate in nongenomic steroid actions[J]. Exp BiolMed (Maywood),2003, 228 (11): 1272-1281.
6Vanacker N J, Palmans, Kips JC, et al.Fluticasone inhibits but does not reverse Allergen induced structural airway changes [J]. Am J Respir Crit Care Med, 2001,163(3)L 674-679.
7Edward T, Naureckas I, Mauriccndukwu, et al. Bronchoalveolar lavage Fluid from Asthmatic Subjects Is Mitogenic for Human Airway Smooth Muscle [J]. AmJ Respir Crit Care Med, 1999,160 (6): 2062-2066.
8Ammit AJ, Pamettieri RA. Siganal Transduction in smooth muscle, InvitedReview: cell cycle regulation in airway smooth muscle [J]. Appl Physiol,2001,91 (3): 1431-1437.
9Femandes D, Guida e, Koutsoubos V, et al. Glucocorticoids inhibit proliferation, cyclinDl expression, and retinoblastoma protein prosphorylation, but not activity of the extracellular-regulated kinasesin human cultured airway smooth muscle [J]. Am J Respir Cell Mol Biol, 1999,21(1): 77-88.
10董宗祈.内皮素的研究进展[J].中国实用儿科杂志,1998,13(4):237-238. 被引量：28

二级参考文献29

1林敏娟,胡成平,吴鄂生,潘频华.支气管哮喘大鼠肺组织中白血病抑制因子的表达变化[J].中华结核和呼吸杂志,2003,26(11):727-728. 被引量：13
2欧阳若芸,胡成平,朱锦琪,黄信刚.神经生长因子及其受体在哮喘大鼠肺组织的变化以及对气道炎症的影响[J].中南大学学报（医学版）,2005,30(6):660-665. 被引量：13
3Lewin GR,Barde YA.Physiology of the neurotrophins[J].Annu Rev Neurosci,1996,19:289-317.(Review)
4Braun A,Lommatzsch M,Renz H.The role of neurotrophins in allergic bronchial asthma[J].Clin Exp Allergy,2000,30 (2):178-186.
5Hu CP,Katrin W,Alexander A,et al.Nerve growth factor and nerve growth factor receptors in respiratory syncytial virus-infected lungs[J].Am J Physiol Lung Cell Mol Physiol,2002,283(2):L494-L502.
6Levi-Montalcini R.The nerve growth factor 35 years later[J].Science,1987,237(4819):1154-1162.
7Bonini S,Lambiase A,Bonini S,et al.Circulating nerve growth factor levels are increased in humans with allergic diseases and asthma[J].Proc Natl Acad Sci USA,1996,93(20):10955-10960.
8Virchow JC,Julius P,Lommatzsch M,et al.Neurotrophins are increased in bronchoalveolar lavage fluid after segmental allergen provocation[J].Am J Respir Crit Care Med,1998,158(6):2002-2005.
9Braun A,Lommatzsch M,Lewin GR,et al.Neurotrophins:a link between airway inflammation and airway smooth muscle contractility in asthma?[J].Int Arch Allergy Immunol,1999,118(2-4):163-165.
10Noga O,Hanf G,Schaper C,et al.The influence of inhalative corticosteroids on circulating nerve growth factor,brain-derived neurotrophic factor and neurotrophin-3 in allergic asthmatics[J].Clin Exp Allergy,2001,31(12):1906-1912.